820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b

Detalles Bibliográficos
Autores principales: Brunetto, Maurizia, Rana, Khurram, Taliani, Gloria, Lawitz, Eric, Hézode, Christophe, Marcellin, Patrick, Serfaty, Lawrence, Cohen, David, Srinivasan, Subasree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781668/
http://dx.doi.org/10.1093/ofid/ofu052.528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781668/
http://dx.doi.org/10.1093/ofid/ofu052.528

Ejemplares similares